After completing this activity, pharmacists should be able to:
- describe the development and role of the lung microbiome in respiratory health;
- describe the gut–lung axis;
- describe the evidence supporting the use of probiotic supplements in preventing and treating respiratory infection.
The 2016 Competency Standards addressed by this activity include: 3.1, 3.2, 3.5, 3.6
Accreditation number: A2009AJP1 Accreditation expires: 01/09/2022
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.